UBS AM’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $83.4M | Sell |
3,023,227
-574,009
| -16% | -$15.8M | 0.02% | 573 |
|
2025
Q1 | $102M | Buy |
3,597,236
+11,270
| +0.3% | +$320K | 0.03% | 529 |
|
2024
Q4 | $149M | Sell |
3,585,966
-304,846
| -8% | -$12.7M | 0.03% | 432 |
|
2024
Q3 | $260M | Buy |
3,890,812
+19,819
| +0.5% | +$1.32M | 0.07% | 275 |
|
2024
Q2 | $460M | Buy |
3,870,993
+197,950
| +5% | +$23.5M | 0.13% | 133 |
|
2024
Q1 | $391M | Buy |
3,673,043
+687,913
| +23% | +$73.3M | 0.14% | 145 |
|
2023
Q4 | $297M | Buy |
2,985,130
+562,058
| +23% | +$55.9M | 0.12% | 179 |
|
2023
Q3 | $250M | Buy |
2,423,072
+957,566
| +65% | +$98.9M | 0.11% | 183 |
|
2023
Q2 | $225M | Hold |
1,465,506
| – | – | 0.11% | 199 |
|
2023
Q1 | $225M | Buy |
1,465,506
+37,179
| +3% | +$5.71M | 0.11% | 199 |
|
2022
Q4 | $257M | Buy |
1,428,327
+183,681
| +15% | +$33M | 0.13% | 178 |
|
2022
Q3 | $147M | Buy |
1,244,646
+32,649
| +3% | +$3.86M | 0.08% | 269 |
|
2022
Q2 | $173M | Sell |
1,211,997
-797
| -0.1% | -$114K | 0.09% | 239 |
|
2022
Q1 | $209M | Sell |
1,212,794
-152,211
| -11% | -$26.2M | 0.09% | 243 |
|
2021
Q4 | $347M | Buy |
1,365,005
+55,735
| +4% | +$14.2M | 0.13% | 169 |
|
2021
Q3 | $504M | Buy |
1,309,270
+111,826
| +9% | +$43M | 0.21% | 103 |
|
2021
Q2 | $281M | Buy |
1,197,444
+263,480
| +28% | +$61.9M | 0.12% | 180 |
|
2021
Q1 | $122M | Sell |
933,964
-1,308
| -0.1% | -$171K | 0.05% | 373 |
|
2020
Q4 | $97.7M | Buy |
935,272
+128,836
| +16% | +$13.5M | 0.05% | 412 |
|
2020
Q3 | $57.1M | Buy |
806,436
+84,951
| +12% | +$6.01M | 0.03% | 480 |
|
2020
Q2 | $46.3M | Buy |
721,485
+412,859
| +134% | +$26.5M | 0.03% | 513 |
|
2020
Q1 | $9.24M | Sell |
308,626
-207,269
| -40% | -$6.21M | 0.01% | 878 |
|
2019
Q4 | $10.1M | Buy |
515,895
+37,552
| +8% | +$735K | 0.01% | 944 |
|
2019
Q3 | $7.62M | Buy |
+478,343
| New | +$7.62M | 0.01% | 1051 |
|